Literature DB >> 2174598

Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses.

R Ogawa1, N Yanagida, S Saeki, S Saito, S Ohkawa, H Gotoh, K Kodama, K Kamogawa, K Sawaguchi, Y Iritani.   

Abstract

The haemagglutinin-neuraminidase gene of Newcastle disease virus was inserted into a non-essential region of the fowlpox virus genome and expressed under control of the vaccinia virus 7.5 kDa polypeptide gene promoter. Immunization with the recombinant fowlpox virus elicited protective immunity in chickens against both virulent Newcastle disease and fowlpox virus infection.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2174598     DOI： 10.1016/0264-410x(90)90251-g

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  13 in total

1.  Development of an effective polyvalent vaccine against both Marek's and Newcastle diseases based on recombinant Marek's disease virus type 1 in commercial chickens with maternal antibodies.

Authors:  K Sonoda; M Sakaguchi; H Okamura; K Yokogawa; E Tokunaga; S Tokiyoshi; Y Kawaguchi; K Hirai
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.

Authors:  Reuben K Soi; Fred R Rurangirwa; Travis C McGuire; Paul M Rwambo; James C DeMartini; Timothy B Crawford
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

3.  Characterization of a recombinant fowlpox virus expressing the native hexon of hemorrhagic enteritis virus.

Authors:  C J Cardona; K Nazerian; W M Reed; R F Silva
Journal:  Virus Genes       Date:  2001-06       Impact factor: 2.332

4.  Identification and expression of a Mycoplasma gallisepticum surface antigen recognized by a monoclonal antibody capable of inhibiting both growth and metabolism.

Authors:  S Yoshida; A Fujisawa; Y Tsuzaki; S Saitoh
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

5.  Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.

Authors:  Sachin Kumar; Baibaswata Nayak; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

6.  Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.

Authors:  H G Heine; D B Boyle
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

7.  Fowlpox virus recombinants expressing the envelope glycoprotein of an avian reticuloendotheliosis retrovirus induce neutralizing antibodies and reduce viremia in chickens.

Authors:  J G Calvert; K Nazerian; R L Witter; N Yanagida
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus.

Authors:  N Yanagida; R Ogawa; Y Li; L F Lee; K Nazerian
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter.

Authors:  E Nagy; P J Krell; R A Heckert; J B Derbyshire
Journal:  Can J Vet Res       Date:  1994-10       Impact factor: 1.310

10.  Protection of chickens from Newcastle disease with a recombinant baculovirus subunit vaccine expressing the fusion and hemagglutininneuraminidase proteins.

Authors:  Youn-Jeong Lee; Haan-Woo Sung; Jun-Gu Choi; Eun-Kyoung Lee; Hachung Yoon; Jae-Hong Kim; Chang-Seon Song
Journal:  J Vet Sci       Date:  2008-09       Impact factor: 1.672
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.